Commentary: Anderson-Fabry Disease: A Rare Cause of Levodopa-Responsive Early Onset Parkinsonism

Mov Disord Clin Pract. 2021 Sep 3;8(Suppl 1):S35-S36. doi: 10.1002/mdc3.13297. eCollection 2021 Aug.

Kailash P Bhatia¹, Ioana Cociasu², Chiara Sorbera³, Antonino Tuttolomondo⁴, Francesca Morgante^{2

5}, Jennifer Friedman^{6

7

8}

¹ Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London United Kingdom.
² Neurosciences Resarch Centre, Molecular and Clinical Sciences Research Institute St George's University of London London United Kingdom.
³ Neurorehabilitation Unit IRCCS Centro Neurolesi "Bonino Pulejo," Messina Italy.
⁴ Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (ProMISE) G. D'Alessandro University of Palermo Palermo Italy.
⁵ Department of Experimental and Clinical Medicine University of Messina Messina Italy.
⁶ Department of Neurosciences and Pediatrics UCSD San Diego California USA.
⁷ Division of Neurology Rady Children's Hospital San Diego California USA.
⁸ Rady Children's Institute of Genomic Medicine San Diego California USA.

No abstract available

Keywords: Anderson‐Fabry disease; early onset parkinsonism; levodopa response; lysosomal storage diseases.

Publication types